These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 37646619)
1. Walking Intensity Preference of Patients With Peripheral Arterial Disease. de Oliveira MD; Kanegusuku H; de Faria DRG; Wolosker N; Correia MA; Ritti-Dias RM J Cardiopulm Rehabil Prev; 2024 Jan; 44(1):71-72. PubMed ID: 37646619 [No Abstract] [Full Text] [Related]
2. Pain-free treadmill exercise for patients with intermittent claudication: Are there gender differences? Dipnarine K; Barak S; Martinez CA; Carmeli E; Stopka CB Vascular; 2016 Jun; 24(3):304-14. PubMed ID: 26209234 [TBL] [Abstract][Full Text] [Related]
3. Physiological responses during walking in men and women with intermittent claudication. Miyasato RS; Felix AJ; Andrade-Lima A; Silva Júnior NDD; Ritti-Dias RM; Wolosker N; Cornelissen V; Goessler KF; Forjaz CLM Einstein (Sao Paulo); 2023; 21():eAO0120. PubMed ID: 38126545 [TBL] [Abstract][Full Text] [Related]
4. The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study). Clavijo LC; Caro J; Choi J; Caro JA; Tun H; Rowe V; Kumar SR; Shavelle DM; Matthews RV Cardiovasc Revasc Med; 2023 Oct; 55():1-5. PubMed ID: 37142533 [TBL] [Abstract][Full Text] [Related]
5. Exercise for intermittent claudication and peripheral arterial disease. Handbook of Non Drug Intervention (HANDI) Project Team Aust Fam Physician; 2013 Dec; 42(12):879. PubMed ID: 24324991 [No Abstract] [Full Text] [Related]
6. Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudication. Afzelius P; Molsted S; Tarnow L Scand J Clin Lab Invest; 2018 Oct; 78(6):456-463. PubMed ID: 30261748 [TBL] [Abstract][Full Text] [Related]
7. Near infrared spectroscopy-guided exercise training for claudication in peripheral arterial disease. Murrow JR; Brizendine JT; Djire B; Young HJ; Rathbun S; Nilsson KR; McCully KK Eur J Prev Cardiol; 2019 Mar; 26(5):471-480. PubMed ID: 30152245 [TBL] [Abstract][Full Text] [Related]
8. ACP Journal Club. Ramipril improved walking times and QOL in peripheral artery disease and intermittent claudication. Jaar BG Ann Intern Med; 2013 Jun; 158(12):JC7. PubMed ID: 23778931 [No Abstract] [Full Text] [Related]
9. The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication. King S; Vanicek N; Mockford KA; Coughlin PA Clin Biomech (Bristol, Avon); 2012 Oct; 27(8):845-51. PubMed ID: 22663776 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of exercise in patients with peripheral arterial disease. Novakovic M; Jug B; Lenasi H Vascular; 2017 Aug; 25(4):412-422. PubMed ID: 28256934 [TBL] [Abstract][Full Text] [Related]
12. Ramipril improves walking times and quality of life in patients with stable intermittent claudication. Brittenden J Evid Based Med; 2014 Feb; 19(1):16. PubMed ID: 23842688 [No Abstract] [Full Text] [Related]
13. Pain threshold is achieved at intensity above anaerobic threshold in patients with intermittent claudication. Ritti-Dias RM; de Moraes Forjaz CL; Cucato GG; Costa LA; Wolosker N; de Fátima Nunes Marucci M J Cardiopulm Rehabil Prev; 2009; 29(6):396-401. PubMed ID: 19770807 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of transcutaneous electrical nerve stimulation on the improvement of walking distance in patients with peripheral arterial disease with intermittent claudication: study protocol for a randomised controlled trial: the TENS-PAD study. Besnier F; Sénard JM; Grémeaux V; Riédel M; Garrigues D; Guiraud T; Labrunée M Trials; 2017 Aug; 18(1):373. PubMed ID: 28797281 [TBL] [Abstract][Full Text] [Related]
15. Effects of walking and strength training on resting and exercise cardiovascular responses in patients with intermittent claudication. Grizzo Cucato G; de Moraes Forjaz CL; Kanegusuku H; da Rocha Chehuen M; Riani Costa LA; Wolosker N; Kalil Filho R; de Fátima Nunes Marucci M; Mendes Ritti-Dias R Vasa; 2011 Sep; 40(5):390-7. PubMed ID: 21948782 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of conservative therapy for intermittent claudication. Masaki H; Tanemoto K Circ J; 2012; 76(6):1327-8. PubMed ID: 22498571 [No Abstract] [Full Text] [Related]
17. The effects of including quality of life responses in models to predict walking performance of patients with intermittent claudication. Leicht AS; Crowther RG; Muller R; Golledge J Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):511-7. PubMed ID: 21247784 [TBL] [Abstract][Full Text] [Related]
19. Real-life adaptations in walking patterns in patients with established peripheral arterial disease assessed using a global positioning system in the community: a cohort study. Klonizakis M; Bianchi SM; Gernigon M; Abraham P; Nawaz S Clin Physiol Funct Imaging; 2018 Sep; 38(5):889-894. PubMed ID: 29368413 [TBL] [Abstract][Full Text] [Related]
20. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]